Home Ingredients Meriva® (Curcumin Phytosome — Indena)
Anti-InflammatoryJoint Health

Meriva® (Curcumin Phytosome — Indena)

Curcuma longa
Evidence Level
Very Strong
3 Clinical Trials
6 Documented Benefits
5/5 Evidence Score

Meriva® is a CURCUMIN PHYTOSOME® formulation developed by Indena (Italy) — using Indena's pioneering Phytosome® technology that complexes curcumin with phosphatidylcholine for enhanced bioavailability. Distinguished by 29× higher curcumin bioavailability vs unformulated curcumin, and one of the most clinically-studied curcumin formulations. Multiple RCTs in osteoarthritis, inflammation, eye health, and metabolic applications. The reference branded curcumin formulation in many published clinical trials.

Studied Dose 1,000 mg/day Meriva (providing ~200 mg curcuminoids); some trials use 500 mg-2 g daily
Active Compound Curcumin Phytosome® (curcumin-phosphatidylcholine complex; 18-22% curcumin)

Benefits

29× Bioavailability Enhancement

Cuomo 2011 pharmacokinetic study showed Meriva provides 29× higher TOTAL curcuminoid bioavailability vs unformulated curcumin. Major improvement addresses curcumin's poor absorption challenge.

Supported by Trial 2

Osteoarthritis (Belcaro 2010 — Foundational)

RCT (n=50, 8 months) showed Meriva 200 mg/day curcumin equivalent significantly improved WOMAC scores, walking distance, and inflammatory markers in OA patients. Foundational Meriva OA evidence.

Supported by Trial 1

Knee OA — Long-Term Tolerability

Belcaro 2014 long-term study (n=100, 8 months) showed Meriva 200 mg/day improved OA symptoms with excellent tolerability. NSAID reduction in many patients.

Supported by Trial 3

Anti-Inflammatory Across Conditions

Multiple Meriva trials show reductions in inflammatory markers (CRP, IL-6, TNF-α) across various inflammatory conditions.

Supported by Trial 1

Diabetic Microangiopathy and Retinopathy

trials showed Meriva improved diabetic retinopathy markers and microvascular function. Eye health applications via Indena's research.

Supported by Trial 1, Trial 2

Inflammatory Bowel and Other Applications

Multiple smaller trials in IBS, dysmenorrhea, post-surgical recovery, exercise recovery — broad anti-inflammatory applications.

Supported by Trial 1

Mechanism of action

1

Phytosome® Technology Bioavailability Enhancement

Indena's PHYTOSOME® TECHNOLOGY complexes plant compounds with PHOSPHATIDYLCHOLINE — creates lipid-compatible structure that enhances absorption through intestinal membrane. Distinguishes from non-phytosome curcumin products.

2

NF-κB and COX-2 Inhibition

Same fundamental anti-inflammatory mechanism as other curcumin products; Meriva's bioavailability advantage delivers more active to inflammation sites.

3

Multiple Inflammatory Pathway Modulation

Curcumin affects NF-κB, AP-1, MAPK, JAK-STAT, inflammasome — pleiotropic anti-inflammatory effects.

4

Antioxidant and NRF2 Activation

Direct antioxidant + induction of endogenous antioxidant systems via NRF2.

Clinical trials

1
Meriva for Osteoarthritis — Belcaro 2010
PubMed

Foundational RCT of Meriva (1,000 mg providing 200 mg curcumin) vs standard care in 50 OA patients for 3 months.

50 osteoarthritis patients.

Significant improvements in WOMAC scores, walking distance, inflammatory markers vs control. Established Meriva OA evidence base.

2
Meriva Bioavailability — Cuomo 2011
PubMed

Pharmacokinetic comparison of Meriva vs unformulated curcuminoids in healthy adults.

Healthy adults.

29× higher total curcuminoid plasma levels with Meriva vs unformulated. Established bioavailability advantage of Phytosome technology.

3
Meriva for Knee OA Long-Term — Belcaro 2014
PubMed

8-month RCT of Meriva 200 mg curcumin equivalent in 100 OA patients.

100 osteoarthritis patients.

Significant symptom improvements; many patients reduced NSAID use; excellent tolerability for chronic use.

Side effects and drug interactions

Common Potential side effects

Generally well-tolerated.
Mild GI distress.
Yellow-orange staining (mouth, urine) — harmless.
Bleeding risk theoretical at high doses.
Allergic reactions to soy lecithin possible (phosphatidylcholine source) — rare; verify product source.
Headache rare.

Important Drug interactions

ANTICOAGULANTS — modest antiplatelet effects; theoretical bleeding.
ANTIPLATELETS — additive bleeding risk.
DIABETES MEDICATIONS — modest hypoglycemic effects.
Pre-surgery — discontinue 1-2 weeks before due to bleeding risk.
Pregnancy — culinary turmeric safe; concentrated curcumin supplementation has limited safety data; AVOID high-dose.
Lactation — culinary use safe; supplementation limited data.
Iron absorption — curcumin may reduce iron absorption modestly.
Gallstones / bile duct obstruction — curcumin has cholagogue effects; AVOID.
SOY ALLERGY — Meriva uses soy-derived phosphatidylcholine; AVOID with severe soy allergy.
Featured In

Symptom-specific supplement guides

👁️Best Supplements for Eye Health🦷Best Supplements for Mouth & Gum Health🍃Best Supplements for Liver Health💎Best Supplements for Skin Health🦴Best Supplements for Joint Pain

More Anti-Inflammatory Ingredients

Cardiovascular
Omega-3 Fatty Acids
Omega-3 fatty acids, primarily eicosapentaenoic acid (EPA), docosahexaenoic acid (DHA), an…
Cardiovascular
Pycnogenol® (French Maritime Pine Bark)
Pycnogenol® (Horphag Research) is a standardized extract from the bark of French maritime…
Cognitive
Longvida® Optimized Curcumin (Verdure Sciences)
Longvida® is a PATENTED CURCUMIN EXTRACT developed by Verdure Sciences using SLCP™ (Solid…
Cognitive
CurQfen® (Curcumin-Fenugreek FenuMat — Akay Bioactives)
CurQfen® is a PATENTED CURCUMIN COMPLEX from Curcuma longa rhizomes formulated with FENUMA…

Frequently asked questions about Meriva® (Curcumin Phytosome — Indena)

What is Meriva® (Curcumin Phytosome — Indena)?

Meriva® is a CURCUMIN PHYTOSOME® formulation developed by Indena (Italy) — using Indena's pioneering Phytosome® technology that complexes curcumin with phosphatidylcholine for enhanced bioavailability.

What does Meriva® (Curcumin Phytosome — Indena) do?

Indena's PHYTOSOME® TECHNOLOGY complexes plant compounds with PHOSPHATIDYLCHOLINE — creates lipid-compatible structure that enhances absorption through intestinal membrane. Distinguishes from non-phytosome curcumin products. In clinical research, Meriva® (Curcumin Phytosome — Indena) has been studied for 29× bioavailability enhancement, osteoarthritis (belcaro 2010 — foundational), knee oa — long-term tolerability.

Who should take Meriva® (Curcumin Phytosome — Indena)?

Meriva® (Curcumin Phytosome — Indena) may be most relevant for people interested in anti-inflammatory, joint health. It has been clinically studied for 29× bioavailability enhancement, osteoarthritis (belcaro 2010 — foundational), knee oa — long-term tolerability. As with any supplement, consult your healthcare provider before starting, especially if you have medical conditions or take prescription medications.

How long does Meriva® (Curcumin Phytosome — Indena) take to work?

Most clinical trial effects appear over weeks of consistent use; individual response varies. Acute or same-day effects (where applicable) typically appear within hours, but most cumulative benefits — particularly those affecting biomarkers, mood, sleep quality, or chronic symptoms — require 4-12 weeks of regular use to fully assess. If you don't notice benefit after 12 weeks at the appropriate dose, it may not be your responder.

When is the best time to take Meriva® (Curcumin Phytosome — Indena)?

For anti-inflammatory and joint goals, Meriva® (Curcumin Phytosome — Indena) is typically taken with meals — fat-containing food often improves absorption for fat-soluble compounds. Daily consistency matters more than precise timing for cumulative anti-inflammatory effects. Always check product labeling and follow personalized guidance from your healthcare provider.

Is Meriva® (Curcumin Phytosome — Indena) worth taking?

Meriva® (Curcumin Phytosome — Indena) has strong clinical evidence (Evidence Level 5/5 on NutraSmarts) for its primary uses, with multiple randomized controlled trials and meta-analyses supporting its benefits. Whether it's worth taking depends on your specific goals, what you've already tried, your budget, and your overall supplement strategy. The honest framing: no supplement is essential for most people, and lifestyle factors (sleep, exercise, diet, stress management) typically produce larger effects than any single supplement. Meriva® (Curcumin Phytosome — Indena) is most worth trying if its evidence-supported uses align with your specific goals.

What is the recommended dosage of Meriva® (Curcumin Phytosome — Indena)?

The clinically studied dose for Meriva® (Curcumin Phytosome — Indena) is 1,000 mg/day Meriva (providing ~200 mg curcuminoids); some trials use 500 mg-2 g daily. Always follow product labeling and consult a healthcare provider for personalized dosing recommendations.

What is Meriva® (Curcumin Phytosome — Indena) used for?

Meriva® (Curcumin Phytosome — Indena) is studied for 29× bioavailability enhancement, osteoarthritis (belcaro 2010 — foundational), knee oa — long-term tolerability. Cuomo 2011 pharmacokinetic study showed Meriva provides 29× higher TOTAL curcuminoid bioavailability vs unformulated curcumin. Major improvement addresses curcumin's poor absorption challenge.